Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Processed-food

HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1CH
June 22, 2020
A man wearing a face mask is seen at a booth at the entrance to a Pepsico food-processing plant in Beijing's...
Beijing, China
Man wearing a face mask is seen at a booth at the entrance to a Pepsico food-processing plant in Beijing...
A man wearing a face mask is seen at a booth at the entrance to a Pepsico food-processing plant in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), in China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1B5
June 22, 2020
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
Beijing, China
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1B3
June 22, 2020
A Pepsico sign is seen at its food-processing plant near a surveillance camera in Beijing's Daxing district,...
Beijing, China
Pepsico sign is seen at its food-processing plant near a surveillance camera in Beijing's Daxing district,...
A Pepsico sign is seen at its food-processing plant near a surveillance camera in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/CHINA-PEPSICO
RTS3F1B2
June 22, 2020
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
Beijing, China
Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak...
A Pepsico sign is seen at its food-processing plant in Beijing's Daxing district, following a new outbreak of the coronavirus disease (COVID-19), China June 22, 2020. REUTERS/Tingshu Wang
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6UG
June 02, 2020
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U9
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U5
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U0
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TX
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TW
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QO
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QN
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QL
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QK
June 02, 2020
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate...
Washington, United States of America
Senate Finance Committee
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration FDA), before leaving the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QI
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QB
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q8
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q7
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q2
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PR
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PQ
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PO
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on as Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6P6
June 02, 2020
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food...
Washington, UNITED STATES
Senate Finance Committee
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LC
June 02, 2020
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability...
Washington, United States of America
Senate Finance Committee
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability Office, left, speaks via teleconference as Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LB
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference as United States Senator Todd Young (Republican of Indiana) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L9
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L8
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L0
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KZ
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KY
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KX
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KT
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KR
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KL
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KK
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KH
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KG
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K6
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K3
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JX
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JT
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JS
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JR
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6HS
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G7
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G3
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G2
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6FJ
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6F3
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6F2
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-MILK
RTS38VJS
May 25, 2020
Bottles of milk are been processed at the South Mountain Creamery farm as coronavirus disease (COVID-19)...
Washington, UNITED STATES
Bottles of milk are been processed at as coronavirus disease (COVID-19) continues to spread in Middletown,...
Bottles of milk are been processed at the South Mountain Creamery farm as coronavirus disease (COVID-19) continues to spread nationwide and public anxiety lingering in grocery stores has created a new surge of interest in home food deliveries, in Middletown, Maryland U.S., May 19, 2020. Picture taken on May 19, 2020. REUTERS/ Carlos Barria
HEALTH-CORONAVIRUS/MEAT-PLANT
RTX7K64H
May 23, 2020
Workers line up to be tested for the coronavirus disease (COVID-19) at the Seaboard Foods hog processing...
GUYMON, UNITED STATES
'We brought the virus home': Oklahoma family loses a father as COVID-19 hits rural America
Workers line up to be tested for the coronavirus disease (COVID-19) at the Seaboard Foods hog processing plant in Guymon, Oklahoma, U.S., May 13, 2020. Picture taken May 13, 2020. REUTERS/Andrew Hay
HEALTH-CORONAVIRUS/MEAT-PLANT
RTX7K64E
May 23, 2020
Workers enter the Seaboard Foods hog processing plant, where the company has introduced temperature screening...
GUYMON, UNITED STATES
'We brought the virus home': Oklahoma family loses a father as COVID-19 hits rural America
Workers enter the Seaboard Foods hog processing plant, where the company has introduced temperature screening and other measures to fight the coronavirus disease (COVID-19) outbreak, in Guymon, Oklahoma, U.S., May 13, 2020. Picture taken May 13, 2020. REUTERS/Andrew Hay
HEALTH-CORONAVIRUS/MEAT-PLANT
RTX7K64D
May 23, 2020
Workers line up to be tested for the coronavirus disease (COVID-19) at the Seaboard Foods hog processing...
GUYMON, UNITED STATES
'We brought the virus home': Oklahoma family loses a father as COVID-19 hits rural America
Workers line up to be tested for the coronavirus disease (COVID-19) at the Seaboard Foods hog processing plant in Guymon, Oklahoma, U.S., May 13, 2020. Picture taken May 13, 2020. REUTERS/Andrew Hay
HEALTH-CORONAVIRUS/MEAT-PLANT
RTX7K64C
May 23, 2020
Workers line up to be tested for the coronavirus disease (COVID-19) at the Seaboard Foods hog processing...
GUYMON, UNITED STATES
'We brought the virus home': Oklahoma family loses a father as COVID-19 hits rural America
Workers line up to be tested for the coronavirus disease (COVID-19) at the Seaboard Foods hog processing plant in Guymon, Oklahoma, U.S., May 13, 2020. Picture taken May 13, 2020. REUTERS/Andrew Hay
HEALTH-CORONAVIRUS/MEAT-PLANT
RTX7K64A
May 23, 2020
The logo of Seaboard Foods hog processing plant, which has tested nearly all its workers for the coronavirus...
GUYMON, UNITED STATES
'We brought the virus home': Oklahoma family loses a father as COVID-19 hits rural America
The logo of Seaboard Foods hog processing plant, which has tested nearly all its workers for the coronavirus disease (COVID-19) after an outbreak at the facility, is seen in Guymon, Oklahoma, U.S., May 13, 2020. Picture taken May 13, 2020. REUTERS/Andrew Hay
HEALTH-CORONAVIRUS/MEATPACKING-FAMILY
RTX7IVVD
May 14, 2020
A Koch Foods sign is seen outside of the processing plant as the coronavirus disease (COVID-19) outbreak...
Morton, UNITED STATES
Coronavirus disease (COVID-19) outbreak in Mississippi
A Koch Foods sign is seen outside of the processing plant as the coronavirus disease (COVID-19) outbreak continues in Morton, Mississippi, U.S. May 9, 2020. Picture taken May 9, 2020. REUTERS/Courtland Wells
HEALTH-CORONAVIRUS/MEATPACKING-FAMILY
RTX7IVVC
May 14, 2020
A general view of the Koch Foods chicken-processing plant, as the coronavirus disease (COVID-19) outbreak...
Morton, UNITED STATES
Coronavirus disease (COVID-19) outbreak in Mississippi
A general view of the Koch Foods chicken-processing plant, as the coronavirus disease (COVID-19) outbreak continues in Morton, Mississippi, U.S. May 9, 2020. Picture taken May 9, 2020. REUTERS/Courtland Wells
HEALTH-CORONAVIRUS/MEATPACKING-FAMILY
RTX7IVVB
May 14, 2020
Workers park at the Koch Foods chicken-processing plant, as the coronavirus disease (COVID-19) outbreak...
Morton, UNITED STATES
Coronavirus disease (COVID-19) outbreak in Mississippi
Workers park at the Koch Foods chicken-processing plant, as the coronavirus disease (COVID-19) outbreak continues in Morton, Mississippi, U.S. May 9, 2020. Picture taken May 9, 2020. REUTERS/Courtland Wells
Coronavirus
Coronavirus
North American meat workers fall sick as supplies dwindle
53 PICTURES
Sort by
Display
Items per page
Page
of 35